At Avellino, we’re on a mission to find cancer before it even exists. By combining the power of genomics, biology, and predictive analytics, we can recognize changes in sample DNA , inclusive of blood, saliva and tumors, that precede cancer and allow individuals the chance to create a plan of action to monitor those changes. Using these unique mutation locations, we can work towards a point where we no longer have to wait for the emergence of cancer cells, tumors, or tumor-derived signals to establish the risk of disease.  The discovery of unique mutation locations has the potential to disrupt and revolutionize how we think about screening. This could change how, when, and where we look for cancer and empower us to assess risk and take action at the earliest opportunity. 자세히 알아보기.